Could a common cholesterol drug ease Parkinson's symptoms?
Disease control
Not yet recruiting
This phase 2 trial is testing whether FHL-301 (gemfibrozil, a drug usually used for cholesterol) can help control motor symptoms in people with early-stage Parkinson's disease. Thirty-two adults aged 40 to 75 will receive either the drug or a placebo for up to 48 weeks. The main …
Phase: PHASE2 • Sponsor: Forest Hills Lab • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC